. 2022 Nov 10;9:936234. doi: 10.3389/fmed.2022.936234

TABLE 2.

Treatment categories.

Treatment categories		No. (%^*)	Gender			Age
			Female	Male	Difference	<18	≥18	Difference^#
Single use	ACU related	146 (7.22)	106	40	χ² = 6.647 P = 0.467 df = 7	3	143	χ² = 4.37 P = 0.668 df = 7
	CHM	1,084 (53.58)	845	239		41	1,043
	PCHMP	26 (1.29)	16	10		0	26
Combinations	ACU related + CHM	152 (7.51)	120	32		2	150
	ACU related +CHM+ PCHMP	44 (2.17)	34	10		1	43
	ACU related + PCHMP	6 (0.30)	4	2		0	6
	CHM+ PCHMP	510 (25.21)	396	114		17	493
No treatment		55 (2.72)	41	14		3	52
Total		2,023 (100)	1,562	461	N/A	67	1,956	N/A
CP	Acute medications	32 (1.58)	N/A
	AEDs	18 (0.89)
	Antidepressants/Antianxiety	61 (3.02)
	CCB	428 (21.16)
	Hypnotic	81 (4.00)
	Sub-total WM	586 (28.97)

ACU, acupuncture; AEDs, Anti-epileptic drugs; CCB, calcium channel blocker; CHM, Chinese herbal medicine; CP, conventional pharmacotherapies; PCHMP, patent Chinese herbal medicine product; N/A, not applicable; No., number.

*Percentage in all patients.

^#Tested by Fisher’s exact test.